Ola Abdelkarim
Overview
Explore the profile of Ola Abdelkarim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Saleh Y, Al-Abcha A, Abdelkarim O, Abdelfattah O, Abela G, Hashim H, et al.
Am J Cardiol
. 2021 Nov;
164:136-138.
PMID: 34815059
No abstract available.
12.
Prasad R, Saleh Y, Al-Abcha A, Abdelkarim O, Abdelfattah O, Abdelnabi M, et al.
Cardiovasc Revasc Med
. 2021 Nov;
40:26-36.
PMID: 34801420
Background: Left atrial appendage closure (LAAC) during cardiac surgery in atrial fibrillation (AF) patients has been investigated in multiple studies with variable safety and efficacy results. Methods: A comprehensive review...
13.
Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi
Saleh Y, Al-Abcha A, Abdelkarim O, Abdelnabi M, Almaghraby A, Kleiman N
Am J Cardiovasc Drugs
. 2021 Nov;
22(3):231-238.
PMID: 34738217
Left ventricular thrombi form due to the presence of Virchow's triad in patients with left ventricular systolic dysfunction. This complication increases the incidence of systemic embolization, hence anticoagulation is recommended...
14.
Saleh Y, Al-Abcha A, Abdelkarim O, Elwany M, Abdelfattah O, Abdelnabi M, et al.
Am J Cardiol
. 2021 Oct;
161:123-125.
PMID: 34656296
No abstract available.
15.
Saleh Y, Al-Abcha A, Abdelkarim O, Abdelnabi M, Almaghraby A
Am J Cardiol
. 2021 May;
150:126-128.
PMID: 33985769
No abstract available.
16.
Abdelnabi M, Saleh Y, Fareed A, Nossikof A, Wang L, Morsi M, et al.
J Am Coll Cardiol
. 2021 Mar;
77(12):1590-1592.
PMID: 33766266
No abstract available.
17.
Al-Abcha A, Saleh Y, Boumegouas M, Prasad R, Herzallah K, Baloch Z, et al.
Am J Cardiol
. 2021 Feb;
146:74-81.
PMID: 33529615
This meta-analysis was conducted to compare clinical outcomes of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-surgical aortic valve replacement (Redo-SAVR) in failed bioprosthetic aortic valves. We conducted a comprehensive...
18.
Al-Abcha A, Herzallah K, Saleh Y, Mujer M, Abdelkarim O, Abdelnabi M, et al.
Am J Cardiovasc Drugs
. 2020 Dec;
21(4):435-441.
PMID: 33354748
Background: Direct oral anticoagulants (DOACs) have a well-established role in the treatment of deep vein thrombosis and pulmonary embolism and in the reduction of thromboembolism in nonvalvular atrial fibrillation. However,...
19.
Al-Abcha A, Saleh Y, Mujer M, Boumegouas M, Herzallah K, Charles L, et al.
Am J Cardiol
. 2020 Jul;
128:101-106.
PMID: 32650901
The Marfan syndrome (MFS) patients are highly predisposed to thoracic aortic aneurysm and/or dissection, with virtually every patient having evidence of aortic disease at some point during their lifetime. We...
20.
Saleh Y, Abdelkarim O, Herzallah K, Abela G
Heart Fail Rev
. 2020 May;
26(5):1159-1173.
PMID: 32410142
Anthracycline is a mainstay in treatment of many cancers including lymphoma and breast cancer among many others. However, anthracycline treatment can be cardiotoxic. Although anthracycline-induced cardiotoxicity is dose dependent, it...